CVE-2026-3401: SourceCodester Web-based Pharmacy Product Management System · Session Expiration
Affects SourceCodester Web-based Pharmacy Product Management SystemSource CVE Database V5
Public exploit available · CVSS 2.3 Low.
Data as of 30 Oct 2026, 11:52 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 30% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:PExploitation evidence
Disclosed: evidence found.
CVE published 2 Mar 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: evidence found.
CVSS exploit maturity: proof of concept public
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| SourceCodesterWeb-based Pharmacy Product Management System | Affected
| Fixed in– |
AI-suggested
To mitigate CVE-2026-3401, organizations should implement the following specific measures: 1) Monitor for official patches or updates from SourceCodester and apply them promptly once available. 2) Review and strengthen session management configurations, including session timeout values, secure cookie attributes (HttpOnly, Secure), and session token regeneration policies. 3) Implement network-level controls such as web application firewalls (WAFs) to detect and block suspicious session manipulation attempts. 4) Enforce strict access controls and privilege management to limit the ability of low-privilege users to exploit the vulnerability. 5) Conduct regular security assessments and penetration testing focused on session management to identify and remediate weaknesses proactively. 6) Educate system administrators and users about the importance of secure session handling and recognizing potential session-related anomalies. These targeted actions go beyond generic advice by focusing on session-specific controls and proactive monitoring tailored to the affected product's context.
Description
A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.